Vanguard Personalized Indexing Management, LLC Amylyx Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $9.45 Billion
- Q3 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 21,101 shares of AMLX stock, worth $293,936. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,101
Previous 21,123
0.1%
Holding current value
$293,936
Previous $135,000
111.85%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AMLX
# of Institutions
150Shares Held
76.1MCall Options Held
212KPut Options Held
40.6K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.8MShares$123 Million0.1% of portfolio
-
Perceptive Advisors LLC New York, NY7.9MShares$110 Million2.22% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$82.8 Million7.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.54MShares$63.2 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$62.7 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $815M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...